Duloxetine Add-On to Risperidone for Treatment of Negative Symptoms in Patients with Stable Schizophrenia: Randomized Double-Blind Placebo-Controlled Study
M.-R. Nikbakhat(Yasuj University of Medical Sciences), Shahin Akhondzadeh(Roozbeh Hospital), Zahra Khalili(Roozbeh Hospital), Farzin Rezaei(Kurdistan University of Medical Sciences), Ali Ghaleiha(Hamedan University of Medical Sciences), Somaye Arabzadeh(Roozbeh Hospital), Atefeh Zeinoddini(Massachusetts General Hospital), Payam Mohammadinejad(Roozbeh Hospital)
Cited by 21
Related Papers
A Survey of Deep-Learning Applications in Ultrasound: Artificial Intelligence–Powered Ultrasound for Improving Clinical Workflow
|Journal of the American College of Radiology|2019|319
N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia
|Clinical Neuropharmacology|2013|154
Comparing the efficacy and safety of<i>Crocus sativus</i>L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial
|Human Psychopharmacology Clinical and Experimental|2014|151
A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients
|Journal of Affective Disorders|2013|135
RIL-Contour: a Medical Imaging Dataset Annotation Tool for and with Deep Learning
|Journal of Imaging Informatics in Medicine|2019|129